China Resources Sanjiu Medical & Pharmaceutical Co LtdNet profit attributable to parent fell 7.90% year-on-year, missing expectations.

China Resources Sanjiu released its 2026 first-half earnings flash, with net profit attributable to the parent of approximately 1.67 billion yuan, a year-on-year decline of 7.90%. The company achieved total operating revenue of about 15.01 billion yuan, up 1.37% year-on-year. Recurring net profit attributable to the parent was approximately 1.6 billion yuan, down 5.87% year-on-year. At the end of the reporting period, total assets stood at about 55.857 billion yuan, equity attributable to the parent was about 22.874 billion yuan, and net assets per share attributable to the parent were 13.74 yuan. The company stated it continues to promote a dual-wheel drive of innovation and brand, strengthening R&D innovation and intelligent digital empowerment. In the first quarter, the company achieved revenue of 8.13 billion yuan and net profit attributable to the parent of 1.076 billion yuan.
China Resources Sanjiu Medical & Pharmaceutical Co LtdNet profit attributable to parent fell 7.90% year-on-year, missing expectations.